InsiderTrades.com logo
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.
Anthony C. J. Fernando net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Anthony Fernando Biography and Net Worth

CEO of Asensus Surgical
As President and Chief Executive Officer, Mr. Fernando sets the company’s overall strategic vision and oversees its organic growth. Previously, he was the Chief Operating Officer and Chief Technology Officer at Asensus, where he led the company’s technology strategy and global business operations.

Prior to Asensus, Mr. Fernando was Vice President of Innovation and Technology within the International Group at Stryker Corporation, across Stryker’s medical device portfolio. Before joining Stryker, Mr. Fernando held positions at Becton Dickinson & Company as Director, R&D Devices & Global Health, Greater Asia; PerkinElmer Inc. as Director, R&D and CoE Leader in Asia; and Varian, Inc. as Director of Operations/General Manager of the Pharmaceutical Products business unit.

Mr. Fernando earned an MBA from the Kenan-Flagler Business School at the University of North Carolina, Chapel Hill, and MS and BS in Mechanical Engineering with concentrations in Robotics and Automation from the University of Nevada-Las Vegas.

What is Anthony C. J. Fernando's net worth?

The estimated net worth of Anthony C. J. Fernando is at least $238,355.34 as of June 8th, 2021. Mr. Fernando owns 685,126 shares of Asensus Surgical stock worth more than $238,355 as of December 22nd. This net worth estimate does not reflect any other investments that Mr. Fernando may own. Additionally, Mr. Fernando receives an annual salary of $901,030.00 as CEO at Asensus Surgical. Learn More about Anthony C. J. Fernando's net worth.

How old is Anthony C. J. Fernando?

Mr. Fernando is currently 52 years old. There are 3 older executives and no younger executives at Asensus Surgical. Learn More on Anthony C. J. Fernando's age.

What is Anthony C. J. Fernando's salary?

As the CEO of Asensus Surgical, Inc., Mr. Fernando earns $901,030.00 per year. Learn More on Anthony C. J. Fernando's salary.

How do I contact Anthony C. J. Fernando?

The corporate mailing address for Mr. Fernando and other Asensus Surgical executives is 1 Tw Alexander Drive, Durham, North Carolina 27703. Asensus Surgical can also be reached via phone at (919) 765-8400 and via email at [email protected]. Learn More on Anthony C. J. Fernando's contact information.

Has Anthony C. J. Fernando been buying or selling shares of Asensus Surgical?

Anthony C. J. Fernando has not been actively trading shares of Asensus Surgical during the past quarter. Most recently, Anthony C. J. Fernando sold 2,112 shares of the business's stock in a transaction on Tuesday, June 8th. The shares were sold at an average price of $3.51, for a transaction totalling $7,413.12. Following the completion of the sale, the chief executive officer now directly owns 685,126 shares of the company's stock, valued at $2,404,792.26. Learn More on Anthony C. J. Fernando's trading history.

Anthony C. J. Fernando Insider Trading History at Asensus Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/8/2021Sell2,112$3.51$7,413.12685,126View SEC Filing Icon  
See Full Table

Anthony C. J. Fernando Buying and Selling Activity at Asensus Surgical

This chart shows Anthony C J Fernando's buying and selling at Asensus Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Asensus Surgical Company Overview

Asensus Surgical logo
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
Read More

Today's Range

Now: $0.35
Low: $0.35
High: $0.35

50 Day Range

MA: N/A

2 Week Range

Now: $0.35
Low: $0.17
High: $0.40

Volume

N/A

Average Volume

2,034,864 shs

Market Capitalization

$94.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.